The present invention relates to a method of treating cancer, comprisingadministering a dose of docetaxel and a dose of rhuMAb HER2 to a patient inneed thereof, wherein said dosages have a synergistic therapeutic effect whencompared to the administration of docetaxel or rhuMAb HER2 alone.